Companies: 10,795·Total market cap: $144.5T
OrthoPediatrics Corp.

OrthoPediatrics Corp.

KIDSNASDAQHealthcare● Active
$18.38
+$0.06(+0.30%)
Market Cap$471961875
P/E Ratio
52W High$23.7
52W Low$14.42

OrthoPediatrics Corp. (KIDS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

kids · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for OrthoPediatrics Corp. (KIDS) measures how much investors pay for each dollar of the company's trailing earnings. KIDS's current PE ratio of N/A is calculated by dividing its stock price of $18.38 by its TTM earnings per share of -$1.68.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.81
Based on 5 analysts
EPS (TTM)
-$1.68
TTM · diluted EPS
PEG Ratio
-7.60
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · OrthoPediatrics Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2014 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 653.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
OrthoPediatrics Corp.
OrthoPediatrics Corp.You
KIDS
$472MN/A-$1.68
Bioventus Inc.
Bioventus Inc.
BVS
$609M21.81x$0.34
CeriBell, Inc.
CeriBell, Inc.
CBLL
$695MN/A-$1.46
Enhabit, Inc.
Enhabit, Inc.
EHAB
$707MN/A-$0.09
Evolus, Inc.
Evolus, Inc.
EOLS
$440MN/A-$0.80
Standard BioTools Inc.
Standard BioTools Inc.
LAB
$318MN/A-$0.20
RxSight, Inc.
RxSight, Inc.
RXST
$204MN/A-$0.95

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 12 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.69
2024-12-31
FY2024
$-1.64
2023-12-31
FY2023
$-0.92
2022-12-31
FY2022
653.89x$0.06
2021-12-31
FY2021
$-0.84
2020-12-31
FY2020
$-1.82
2019-12-31
FY2019
$-0.94
2018-12-31
FY2018
$-0.96
2017-12-31
FY2017
$-1.85
2016-12-31
FY2016
$-0.87

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for OrthoPediatrics Corp. (KIDS) measures how much investors pay for each dollar of the company's trailing earnings. KIDS's current PE ratio of N/A is calculated by dividing its stock price of $18.38 by its TTM earnings per share of -$1.68.

PE Ratio = Stock Price ÷ EPS (TTM)
= $18.38 ÷ -$1.68 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

KIDS pe ratio · 6 questions

KIDS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $18.38 and TTM EPS of -$1.68. Data sourced from Financial Modeling Prep via KIDS's SEC 10-K and 10-Q filings.

KIDS PE ratioWhat is KIDS PE ratioCurrent PE ratio of KIDSKIDS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · OrthoPediatrics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08